Al-Eidan A, Draper B, Wang S, Coke B, Skipp P, Wang Y
Mol Cell Proteomics. 2024; 23(12):100878.
PMID: 39522755
PMC: 11697772.
DOI: 10.1016/j.mcpro.2024.100878.
Li X, Pan J, Zheng P
Front Oncol. 2024; 14:1427663.
PMID: 39346740
PMC: 11427698.
DOI: 10.3389/fonc.2024.1427663.
Tan H, Li C, Lai T, Luo L
Mar Drugs. 2024; 22(1).
PMID: 38276639
PMC: 10817464.
DOI: 10.3390/md22010001.
Ren J, Yu P, Liu S, Li R, Niu X, Chen Y
Adv Sci (Weinh). 2023; 10(36):e2303807.
PMID: 37888853
PMC: 10754134.
DOI: 10.1002/advs.202303807.
Liu X, Burke R, Lighthouse J, Baker C, Dirkx Jr R, Kang B
Circ Res. 2023; 133(3):271-287.
PMID: 37409456
PMC: 10361635.
DOI: 10.1161/CIRCRESAHA.121.320324.
USP7 inactivation suppresses APC-mutant intestinal hyperproliferation and tumor development.
Novellasdemunt L, Kucharska A, Baulies A, Hutton C, Vlachogiannis G, Repana D
Stem Cell Reports. 2023; 18(2):570-584.
PMID: 36669491
PMC: 9968985.
DOI: 10.1016/j.stemcr.2022.12.013.
DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities.
Abuetabh Y, Wu H, Chai C, Al Yousef H, Persad S, Sergi C
Exp Mol Med. 2022; 54(10):1658-1669.
PMID: 36207426
PMC: 9636249.
DOI: 10.1038/s12276-022-00863-4.
MDMX Regulates Transcriptional Activity of p53 and FOXO Proteins to Stimulate Proliferation of Melanoma Cells.
Heijkants R, Teunisse A, de Jong D, Glinkina K, Mei H, Kielbasa S
Cancers (Basel). 2022; 14(18).
PMID: 36139642
PMC: 9496676.
DOI: 10.3390/cancers14184482.
p53 as a unique target of action of cisplatin in acute leukaemia cells.
Kumar S, Tchounwou P
J Cell Mol Med. 2022; 26(17):4727-4739.
PMID: 35946055
PMC: 9443951.
DOI: 10.1111/jcmm.17502.
Methyltransferase-like 3 Aggravates HCC Development via Mediating N6-Methyladenosine of Ubiquitin-Specific Protease 7.
Yuan D, Chen J, Hao Q, Zhang P, Chen Z
J Oncol. 2022; 2022:6167832.
PMID: 35571490
PMC: 9098324.
DOI: 10.1155/2022/6167832.
Organ defects of the Usp7 mutant mouse strain indicate the essential role of K63-polyubiquitinated Usp7 in organ formation.
Wu H, Lin Y, Chew S, Wu K
Biomed J. 2022; 46(1):122-133.
PMID: 35183794
PMC: 10104958.
DOI: 10.1016/j.bj.2022.02.002.
METTL3 facilitates the progression of hepatocellular carcinoma by modulating the m6A level of USP7.
Li Y, Cheng X, Chen Y, Zhou T, Li D, Zheng W
Am J Transl Res. 2022; 13(12):13423-13437.
PMID: 35035685
PMC: 8748139.
Timely upstream events regulating nucleotide excision repair by ubiquitin-proteasome system: ubiquitin guides the way.
Chauhan A, Sun Y, Zhu Q, Wani A
DNA Repair (Amst). 2021; 103:103128.
PMID: 33991872
PMC: 8206018.
DOI: 10.1016/j.dnarep.2021.103128.
USP7 Is a Master Regulator of Genome Stability.
Valles G, Bezsonova I, Woodgate R, Ashton N
Front Cell Dev Biol. 2020; 8:717.
PMID: 32850836
PMC: 7419626.
DOI: 10.3389/fcell.2020.00717.
The SUMO-specific protease SENP1 deSUMOylates p53 and regulates its activity.
Chauhan K, Chen Y, Chen Y, Liu A, Sun X, Dai M
J Cell Biochem. 2020; 122(2):189-197.
PMID: 32786121
PMC: 7802976.
DOI: 10.1002/jcb.29838.
The multiple roles of deubiquitinases in liver cancer.
Lv X, Duan T, Li J
Am J Cancer Res. 2020; 10(6):1647-1657.
PMID: 32642281
PMC: 7339268.
Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells.
Pu Q, Lv Y, Dong K, Geng W, Gao H
BMC Cancer. 2020; 20(1):583.
PMID: 32571254
PMC: 7310228.
DOI: 10.1186/s12885-020-07069-9.
Regulating tumor suppressor genes: post-translational modifications.
Chen L, Liu S, Tao Y
Signal Transduct Target Ther. 2020; 5(1):90.
PMID: 32532965
PMC: 7293209.
DOI: 10.1038/s41392-020-0196-9.
Coupling Conjugation and Deconjugation Activities to Achieve Cellular Ubiquitin Dynamics.
Nielsen C, MacGurn J
Trends Biochem Sci. 2020; 45(5):427-439.
PMID: 32311336
PMC: 7176742.
DOI: 10.1016/j.tibs.2020.01.008.
Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?.
Qi S, Cheng G, Cheng X, Xu Z, Xu B, Zhang W
Front Cell Dev Biol. 2020; 8:233.
PMID: 32300595
PMC: 7142254.
DOI: 10.3389/fcell.2020.00233.